Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

AZN 4,136.50 -64.50 (-1.54%)
price chart
AstraZeneca Antitrust Fine Should Stand, EU Court Aide Says
May 15 (Bloomberg) -- AstraZeneca Plc, the U.K.'s second-biggest drugmaker, shouldn't get a further reduction in an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union's highest court said.
Amylin Said to Attract Interest From Pfizer, AstraZeneca
May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter.
Plavix Patent Loss Doesn't Mean Gain by Competing Blood Thinners
May 17 (Bloomberg) -- Eli Lilly & Co. and AstraZeneca Plc won't have an easier time gaining more of the market for blood thinners dominated by Bristol-Myers Squibb Co.
Boards wake up to a shareholder spring
Two weeks ago David Brennan, chief executive of AstraZeneca, bowed to pressure from the pharmaceutical group's top shareholders and stepped down at the annual meeting.
Aviva chief resigns after shareholder uprising
The resignation of Moss followed the high-profile exits of Sly Bailey from Trinity Mirror and David Brennan from AstraZeneca last week as a result of shareholder hostility. Aviva shares, which have fallen a third in a year, were up 4% on the news. Lord ...
UK Pay Protests Oust Aviva Chief  Wall Street Journal
Solid returns from infrastructure funds come at a cost
The UK government's National Infrastructure Plan has helped focus attention on opportunities for investing in areas such as schools, hospitals and transport, in many cases through public private partnerships ( PPP and P3) or private finance initiative ...
EU to push for binding investor pay votes
Shareholders in Europe's listed companies will be given a binding vote on pay while those who invest in banks will gain powers to set a cap on bonus levels, under plans being drawn up by senior EU officials.
Stock to Watch: British American Tobacco
This article is for information and discussion purposes only and does not form a recommendation to invest or otherwise. The value of an investment may fall.
Drugmakers see $33bn bout of M&A activity
While the appetite for “mega mergers” has dulled, several midsize companies including Shire and Biogen Idec are regularly cited as potential targets.
EU Joins Widening Push to Find New Antibiotics
"Antibiotics are fundamental for the practice of medicine," says John Rex, vice-president of clinical infection at AstraZeneca PLC." Without them you cannot get your heart valve replaced, take care of a premature infant, get your cancer treated, or ...